Arch Therapeutics Inc (ARTH)

[Amatuer17]

The share count

Current o/s shares - 140 million
Today's offering - 10 million
Stock options - 14 million

Total - 164 million

O/s warrants - series A to F - maybe around 25+ million (not sure exactly)

So we are around 190 million total

We could see one more round of dilution this year. I hope they do it after CE filing which will allow them to raise money at much higher SP.

For no-revenue biotechs - 200 million o/s is becoming norm - so of them do r/s to increase SP and uplist to Nasdaq - so no looks small.